300
Participants
Start Date
August 7, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
COR-1167
28-day treatment
Placebo
28-day treatment
NOT_YET_RECRUITING
South Oklahoma Heart Research, LLC, Oklahoma City
RECRUITING
Aleksandre Aladashvili Clinic LLC, Tbilisi
RECRUITING
"LTD Israeli-Georgian Medical Research Clinic Healthycore", Tbilisi
NOT_YET_RECRUITING
Acad. G. Chapidze Emergency Cardiology Center LTD, Department of Internal Medicine and Medical Research, Tbilisi
RECRUITING
Acad. G.Chapidze Emergency Cardiology Center, LTD, Department of Multi-center Clinical Trials, Tbilisi
NOT_YET_RECRUITING
Bokhua Memorial Cardiovascular Center LTD, Tbilisi
NOT_YET_RECRUITING
St. Michael's Hospital LLC, Tbilisi
NOT_YET_RECRUITING
Tbilisi Heart and Vascular Clinic, LTD, Tbilisi
RECRUITING
Georgian Dutch Hospital, Tbilisi
NOT_YET_RECRUITING
LTD Tbilisi Heart Center, Tbilisi
Lead Sponsor
Collaborators (1)
Worldwide Clinical Trials
OTHER
Corteria Pharmaceuticals
INDUSTRY